Luigi Bonfatti is Executive Advisor at RVMC (Regionalized Vaccine Manufacturing Collaborative). As member of RVMC Leadership he has global accountability on industry (and industry associations) engagement as well as for Asia regionalization agenda. Before joining RVMC, Luigi has been supporting Chiesi Farmaceutici, Italian largest pharma company, in managing the integration of its largest acquisition to date (a fully fledged rare disease company) and adjust its operating and governance business models. Prior to that, Luigi has spent 25 years at GSK Vaccines in a variety of senior roles in business development, supply, marketing and strategy of growing importance. During the last 8 years at GSK he created and grew a self-standing business unit in charge of integrations, divestments and strategic partnerships. As general manager of this business unit, Luigi was overseeing commercial and industrial partnerships and product transfers allowing him to have a unique end-to-end understanding of the vaccine industry and value chain. Luigi holds a chemical engineering degree from Polytechnic School of Brussels University as well as an MBA from Solvay Business School.